MAIA

$2.87 0.03 (1.06%)

20:00 EDT MAIA Stock Quote Delayed 30 Minutes

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024

By InvestorPlace Earnings May 15, 2024

MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the first quarter of 2024.

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

7 Up-and-Coming Stocks to Buy for the Next Decade

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 87,620

Day's Range $2.84 - $2.99

52-Week Range $0.82 - $3.59

Dividend & Yield N/A (N/A)

MAIA Stock Predictions, Articles, and News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 25, 2023

It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 3, 2022

It's time for another dive into the biggest pre-market stock movers as we check out the latest news investors need to know about Wednesday!

Why Is MAIA Biotechnology (MAIA) Stock Soaring 15% Higher Today?

By Larry Ramer, InvestorPlace Contributor Aug 1, 2022

MAIA stock is rallying this morning on heavy volume. The drugmaker's stock began trading on Thursday following its IPO.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Aug 1, 2022

Good morning, trader! We're starting off Monday with a breakdown of the biggest pre-market stock movers traders will want to watch!

MAIA shares continue downward slide amid warrant issuance (NYSE:MAIA)

From Seeking Alpha Nov 17, 2023

Shares of MAIA (MAIA) tumbled Friday, the day after the biotech company said it had issued a warrant to Alumni Capital for the purchase of up to 239K shares. Read more here.

MAIA stock climbs on positive Phase 2 data for lung cancer therapy (MAIA)

From Seeking Alpha Oct 24, 2023

MAIA (MAIA) stock climbed 6% after the company reported positive Phase 2 data for its immunotherapy THIO in treating advanced non-small cell lung cancer. Read more here.

MAIA shares fall 17% pre-market after rallying in prior session (NYSE:MAIA)

From Seeking Alpha Oct 3, 2023

Shares of MAIA Biotechnology (MAIA) fell 17% in pre-market trading after gaining 16% in the prior session. Read more here.

MAIA Biotechnology announces share repurchase program (NYSE:MAIA)

From Seeking Alpha Sep 28, 2023

MAIA Biotechnology announces a share repurchase program, authorizing the purchase of up to $800,000 of its Class A common stock, leading to a positive stock...

ADVERTISEMENT